Zions Bancorporation, N.A. (NASDAQ:ZION), listed on the Russell 1000 Index and operating in the regional banking sector.

PROCEPT BioRobotics Corporation (NASDAQ:PRCT), listed on the NASDAQ Composite and part of the healthcare technology sector.

Health care stocks rose Monday afternoon with the NYSE Health Care Index climbing 0.2% and the Healt PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold ...

Microsoft has developed an artificial intelligence (AI) system that it claims is four times better than doctors at diagnosing complex illnesses. The tech company’s AI diagnosis system was able to ...

Shheikh.io, an AI-powered Web3 platform, has announced the launch of its marketplace for fractional ownership of luxury real estate and other high-value assets. The platform aims to facilitate access ...

Artificial intelligence circuit board 5] Jonathan Kitchen In a bid to lead the next wave of AI innovation, Meta (NASDAQ:META [ is creating a “superintelligence” division dedicated to developing ...

Brazilian central bank figures released on Monday show a slight rise in the public sector gross debt to 76.1 per cent of gross domestic product (GDP) in May versus 76.0 per cent in April. The modest ...

Alzheimers Concept Horizontal] travellinglight/iStock via Shares of INmune Bio (NASDAQ:INMB [ dropped on Monday after the company did not achieve the main goal in a mid-stage trial for its TNF ...

Sandvik will publish its second quarter results on Wednesday, July 16, 2025, at approximately 11:30 AM CEST. A combined webcast and conference call for investors, analysts and financial media will be ...

Siemens has recruited Amazon executive Vasi Philomin to its new position of head of data and artificial intelligence, the German technology company said on Monday. The move is the latest step by ...

(Reuters) -TransDigm Group said on Monday it will acquire Simmonds Precision Products from RTX Corp for about $765 million in cash.

Revolution Medicines, Inc. (RVMD) and Summit Therapeutics, Inc. (SMMT) have entered into a clinical collaboration in multiple solid tumor settings to evaluate the safety and efficacy of each of ...